)
)
Jounce Therapeutics Investor Relations Material
Latest events
Business Combination
Jounce Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Jounce Therapeutics Inc
Access all reports
Jounce Therapeutics Inc. is a clinical-stage biotechnology company focused on developing immunotherapies for the treatment of cancer. The company leverages its expertise in immuno-oncology to discover and develop therapies that stimulate the immune system to recognize and attack tumors. Jounce's pipeline includes a range of biologic therapies that target various immune pathways, with the goal of improving patient outcomes in solid tumor cancers. The company collaborates with academic institutions and industry partners to advance its therapeutic candidates. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the Nasdaq.
Latest articles
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Ticker symbol
JNCE
Country
🇺🇸 United States